Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Tiffany Lin

Tiffany Lin, PharmD, BCPS, BCOP is an oncology pharmacist at Cedars-Sinai Medical Center, 8700 Beverly Blvd., Los Angeles, CA 90048, United States.

Contact Info

Email:
Tiffany.Lin@cshs.org

Recent stories

  • Close up of kidney with renal cell carcinoma

    Mammalian target of rapamycin (mTOR) inhibitors in solid tumoursSubscription

    9 MAR 2016

    The phosphatidylinositol-3-kinase /protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway plays an important role in cell proliferation, growth, and angiogenesis. mTOR is a critical signalling protein as it serves as precursor to many pathways related to cell growth and survival. When this major pathway is dysregulated, it can cause uninhibited activation of cancer cell growth and proliferation. This commonly results in malignancies that affect the kidney, breast and neuroend

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.